GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Varex Imaging Corp (NAS:VREX) » Definitions » Beneish M-Score
中文

Varex Imaging (Varex Imaging) Beneish M-Score : -2.81 (As of Apr. 24, 2024)


View and export this data going back to 2017. Start your Free Trial

Varex Imaging Beneish M-Score Definition

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.81 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Varex Imaging's Beneish M-Score or its related term are showing as below:

VREX' s Beneish M-Score Range Over the Past 10 Years
Min: -3.53   Med: -2.66   Max: -2.11
Current: -2.81

During the past 11 years, the highest Beneish M-Score of Varex Imaging was -2.11. The lowest was -3.53. And the median was -2.66.


Varex Imaging Beneish M-Score Historical Data

The historical data trend for Varex Imaging's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Varex Imaging Beneish M-Score Chart

Varex Imaging Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.72 -2.78 -2.64 -2.29 -2.68

Varex Imaging Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.11 -2.47 -2.61 -2.68 -2.81

Competitive Comparison of Varex Imaging's Beneish M-Score

For the Medical Devices subindustry, Varex Imaging's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Varex Imaging Beneish M-Score Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Varex Imaging's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Varex Imaging's Beneish M-Score falls into.



Varex Imaging Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Varex Imaging for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8724+0.528 * 1.0059+0.404 * 0.9769+0.892 * 1.0134+0.115 * 1.0354
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1149+4.679 * -0.047332-0.327 * 0.948
=-2.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $139.6 Mil.
Revenue was 190 + 227.4 + 232.2 + 228.2 = $877.8 Mil.
Gross Profit was 57.1 + 78 + 76.3 + 72.7 = $284.1 Mil.
Total Current Assets was $645.7 Mil.
Total Assets was $1,242.3 Mil.
Property, Plant and Equipment(Net PPE) was $176.7 Mil.
Depreciation, Depletion and Amortization(DDA) was $33.9 Mil.
Selling, General, & Admin. Expense(SGA) was $130.5 Mil.
Total Current Liabilities was $150.1 Mil.
Long-Term Debt & Capital Lease Obligation was $464.3 Mil.
Net Income was -0.5 + 31.9 + 9.1 + 4.1 = $44.6 Mil.
Non Operating Income was 0.6 + -17.7 + -0.7 + -1.2 = $-19.0 Mil.
Cash Flow from Operations was 10.3 + 47.1 + 37.7 + 27.3 = $122.4 Mil.
Total Receivables was $157.9 Mil.
Revenue was 205.6 + 231.4 + 214.5 + 214.7 = $866.2 Mil.
Gross Profit was 63.3 + 74.5 + 73.4 + 70.8 = $282.0 Mil.
Total Current Assets was $607.3 Mil.
Total Assets was $1,180.9 Mil.
Property, Plant and Equipment(Net PPE) was $165.0 Mil.
Depreciation, Depletion and Amortization(DDA) was $33.0 Mil.
Selling, General, & Admin. Expense(SGA) was $115.5 Mil.
Total Current Liabilities was $157.4 Mil.
Long-Term Debt & Capital Lease Obligation was $458.7 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(139.6 / 877.8) / (157.9 / 866.2)
=0.159034 / 0.18229
=0.8724

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(282 / 866.2) / (284.1 / 877.8)
=0.32556 / 0.32365
=1.0059

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (645.7 + 176.7) / 1242.3) / (1 - (607.3 + 165) / 1180.9)
=0.338002 / 0.346007
=0.9769

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=877.8 / 866.2
=1.0134

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(33 / (33 + 165)) / (33.9 / (33.9 + 176.7))
=0.166667 / 0.160969
=1.0354

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(130.5 / 877.8) / (115.5 / 866.2)
=0.148667 / 0.133341
=1.1149

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((464.3 + 150.1) / 1242.3) / ((458.7 + 157.4) / 1180.9)
=0.494567 / 0.521721
=0.948

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(44.6 - -19 - 122.4) / 1242.3
=-0.047332

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Varex Imaging has a M-score of -2.81 suggests that the company is unlikely to be a manipulator.


Varex Imaging Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Varex Imaging's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Varex Imaging (Varex Imaging) Business Description

Traded in Other Exchanges
Address
1678 South Pioneer Road, Salt Lake City, UT, USA, 84104
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, ionization chambers, and buckys among others. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors and high voltage connectors among others. It has manufacturing, research, and development operation in the United States, Europe, Philippines and China, and sales and service operations throughout the world.
Executives
Kimberley E. Honeysett officer: Vice President and Secretary 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Jay K. Kunkel director 21557 TELEGRAPH ROAD, SOUTHFIELD MI 48033
Ruediger Naumann-etienne director
Kathleen Bardwell director 9 BLACKBERRY DRIVE, HUDSON OH 44236
Sunny Sanyal director, officer: President and CEO 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Kevin Bruce Yankton officer: Controller & CAO 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Andrew Hartmann officer: SVP Sales & Marketing, Medical 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Timothy E Guertin director C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
Shubham Maheshwari officer: Chief Financial Officer C/O VEECO INSTRUMENTS INC., 1 TERMINAL DRIVE, PLAINVIEW NY 11803
Brian W Giambattista officer: SVP and GM, X-ray Detectors 1678 SOUTH PIONEER ROAD, SALT LAKE CITY UT 84104
Erich R Reinhardt director VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Mark S. Jonaitis officer: SVP and GM, X-Ray Sources 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Clarence R Verhoef officer: SVP & Chief Financial Officer VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 95035
Rosebrough Walter M Jr director 5960 HEISLEY ROAD, MENTOR OH 44060
Carl E. Lacasce officer: SVP, Sales & Marketing 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104

Varex Imaging (Varex Imaging) Headlines